AAAAAA

   
Results: 1-8 |
Results: 8
PHASE-I STUDY OF ANTI-IGE RECOMBINANT HUMANIZED MONOCLONAL-ANTIBODY RHUMAB-E25 (E25) IN ADULTS WITH MODERATE TO SEVERE ASTHMA
Authors: CORREN J FROEHLICH J SCHOENHOFF M SPECTOR S RACHELEFSKY G SCHANKER H PATNAIK M SIEGEL S
Citation: J. Corren et al., PHASE-I STUDY OF ANTI-IGE RECOMBINANT HUMANIZED MONOCLONAL-ANTIBODY RHUMAB-E25 (E25) IN ADULTS WITH MODERATE TO SEVERE ASTHMA, Journal of allergy and clinical immunology, 97(1), 1996, pp. 251-251
A PHASE-I, SINGLE-BLIND STUDY TO DETERMINE THE SAFETY, TOLERANCE, PHARMACOKINETICS AND PHARMACODYNAMICS OF ANTI-IGE RECOMBINANT HUMANIZED MONOCLONAL-ANTIBODY E25 (RHUMAB-E25) IN ADOLESCENTS AND CHILDREN WITH MODERATE TO SEVERE ALLERGIC-ASTHMA
Authors: BISBERG D FROEHLICH J SCHOENHOFF M MENDELSON J
Citation: D. Bisberg et al., A PHASE-I, SINGLE-BLIND STUDY TO DETERMINE THE SAFETY, TOLERANCE, PHARMACOKINETICS AND PHARMACODYNAMICS OF ANTI-IGE RECOMBINANT HUMANIZED MONOCLONAL-ANTIBODY E25 (RHUMAB-E25) IN ADOLESCENTS AND CHILDREN WITH MODERATE TO SEVERE ALLERGIC-ASTHMA, Pediatric research, 39(4), 1996, pp. 39-39
SITE-SPECIFIC COUPLING OF MONOMETHOXYPOLY(ETHYLENE GLYCOL) TO A SINGLE-SULFHYDRYL HUMANIZED FAB
Authors: ZAPATA G BATES D SCHOENHOFF M DEVENEY J FRIE S SNEDECOR B CARTER P CHAMOW SM
Citation: G. Zapata et al., SITE-SPECIFIC COUPLING OF MONOMETHOXYPOLY(ETHYLENE GLYCOL) TO A SINGLE-SULFHYDRYL HUMANIZED FAB, The FASEB journal, 9(6), 1995, pp. 1479-1479
PHARMACOKINETICS DYNAMICS FOLLOWING ADMINISTRATION OF A RECOMBINANT HUMANIZED MONOCLONAL ANTI IGE ANTIBODY IN THE CYNOMOLGUS MONKEY/
Authors: SCHOENHOFF M BATES D RUPPEL J FEI D FOX JA THOMAS D JARDIEU P
Citation: M. Schoenhoff et al., PHARMACOKINETICS DYNAMICS FOLLOWING ADMINISTRATION OF A RECOMBINANT HUMANIZED MONOCLONAL ANTI IGE ANTIBODY IN THE CYNOMOLGUS MONKEY/, Journal of allergy and clinical immunology, 95(1), 1995, pp. 356-356
MULTIPLE DOSES OF A RECOMBINANT HUMANIZED MONOCLONAL ANTI IGE ANTIBODY ARE SAFELY TOLERATED AND DECREASE FREE SERUM IGE TO UNDETECTABLE LEVELS
Authors: FROEHLICH J SCHOENHOFF M JARDIEU P RUPPEL J FEI D BUCKLEY P BUSH R
Citation: J. Froehlich et al., MULTIPLE DOSES OF A RECOMBINANT HUMANIZED MONOCLONAL ANTI IGE ANTIBODY ARE SAFELY TOLERATED AND DECREASE FREE SERUM IGE TO UNDETECTABLE LEVELS, Journal of allergy and clinical immunology, 95(1), 1995, pp. 356-356
INITIAL HUMAN STUDY WITH A HUMANIZED RECOMBINANT ANTI-IGE MONOCLONAL-ANTIBODY - SAFETY, TOLERANCE AND PHARMACOKINETIC (PK) DYNAMIC PROFILE
Authors: FROEHLICH J SCHOENHOFF M TREMBLAY T RUPPEL J JARDIEU P
Citation: J. Froehlich et al., INITIAL HUMAN STUDY WITH A HUMANIZED RECOMBINANT ANTI-IGE MONOCLONAL-ANTIBODY - SAFETY, TOLERANCE AND PHARMACOKINETIC (PK) DYNAMIC PROFILE, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 162-162
ADMINISTRATION OF AN ANTI-IGE ANTIBODY INHIBITS CD23 EXPRESSION AND IGE PRODUCTION IN-VIVO
Authors: HAAKFRENDSCHO M ROBBINS K LYON R SHIELDS R HOOLEY J SCHOENHOFF M JARDIEU P
Citation: M. Haakfrendscho et al., ADMINISTRATION OF AN ANTI-IGE ANTIBODY INHIBITS CD23 EXPRESSION AND IGE PRODUCTION IN-VIVO, Immunology, 82(2), 1994, pp. 306-313
LONG-TERM SUPPRESSION OF ANTIGEN-SPECIFIC IGE SYNTHESIS IN ADULT MICE
Authors: HAAKFRENDSCHO M HOOLEY J SCHOENHOFF M LYON R JARDIEU P
Citation: M. Haakfrendscho et al., LONG-TERM SUPPRESSION OF ANTIGEN-SPECIFIC IGE SYNTHESIS IN ADULT MICE, The Journal of immunology, 150(8), 1993, pp. 61-61
Risultati: 1-8 |